Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,20461,1174,1.23 [1.06-1.42],0.006120158764198
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,24101,1383,1.10 [1.03-1.18],0.0041912991639404
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23618,1368,1.16 [1.10-1.23],2.500695973873907e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAN,Aggrecan core protein,23987,1381,0.76 [0.64-0.90],0.0014093317743916
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,23739,1376,1.55 [1.41-1.69],2.754263170267733e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,20528,1188,0.85 [0.75-0.97],0.0127651785839425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,24299,1407,1.25 [1.09-1.45],0.001755964362649
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,24361,1398,1.11 [1.03-1.19],0.0061857930664003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",23739,1376,1.12 [1.01-1.23],0.0269305564762047
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTN2,Alpha-actinin-2,20461,1174,1.11 [1.01-1.23],0.0332904350841387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,23992,1371,2.32 [1.95-2.75],4.721552868171149e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,24200,1394,1.28 [1.19-1.38],1.0388636380301344e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20461,1174,1.17 [1.06-1.29],0.001339109748012
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA,Adenosine deaminase,24435,1413,1.26 [1.11-1.43],0.0004194035683902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20528,1188,1.34 [1.22-1.48],4.2912760265561055e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24033,1375,0.85 [0.74-0.98],0.0237407119271537
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21010,1209,1.41 [1.18-1.69],0.0001436143135969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20528,1188,1.23 [1.05-1.44],0.0099662697831874
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24485,1416,0.69 [0.56-0.85],0.0004368152894436
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24101,1383,1.20 [1.07-1.34],0.0023429036667306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,23739,1376,1.19 [1.06-1.34],0.0025955043034443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20528,1188,1.34 [1.15-1.56],0.000160420864275
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24272,1406,0.89 [0.80-0.99],0.0345493273484681
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,21122,1217,1.87 [1.58-2.21],1.3930563690189174e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,20595,1191,1.39 [1.11-1.75],0.0041908867591603
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,20675,1203,1.38 [1.19-1.60],1.7205903034528125e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,24314,1410,0.74 [0.63-0.88],0.0004974118788513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,24364,1410,0.74 [0.63-0.87],0.0002617379877262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,21125,1219,1.30 [1.09-1.55],0.0030815598181021
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,24101,1383,1.19 [1.10-1.28],1.6149712222120504e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,24200,1394,0.68 [0.57-0.81],1.2060168200268324e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,20675,1203,1.13 [1.05-1.22],0.000789128464116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,23739,1376,1.12 [1.06-1.18],7.93107732199571e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,24400,1401,2.15 [1.80-2.58],7.560908821951642e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,24157,1400,0.88 [0.78-0.98],0.0239344298269411
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,23416,1343,1.16 [1.11-1.22],2.3522813769201354e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR3,Anterior gradient protein 3,23576,1366,1.23 [1.14-1.33],3.1439393312123146e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,24314,1410,1.62 [1.43-1.84],4.6553014646523477e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRP,Agouti-related protein,24435,1413,1.21 [1.11-1.33],2.0175192971091505e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,24200,1394,1.13 [1.06-1.20],7.576996440818341e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,20595,1191,1.23 [1.04-1.45],0.0156993236724326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24055,1380,1.07 [1.03-1.12],0.0022150882885003
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,23618,1368,1.07 [1.00-1.14],0.0381985454569691
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,23739,1376,1.09 [1.01-1.17],0.0243169574187064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24108,1395,1.30 [1.23-1.37],1.5285394225647432e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",24101,1383,1.40 [1.34-1.46],2.792822708155567e-56
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBN,Ameloblastin,23703,1359,0.82 [0.69-0.98],0.0301011377242156
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,24365,1399,1.87 [1.48-2.37],2.221051201167483e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMN,Protein amnionless,23703,1359,1.13 [1.03-1.24],0.0122688069983143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19794,1153,0.83 [0.74-0.94],0.0027198971028293
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2A,Pancreatic alpha-amylase,23216,1356,0.86 [0.78-0.95],0.0032827012791696
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMY2B,Alpha-amylase 2B,22520,1308,0.87 [0.79-0.96],0.0060799594344365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,24105,1392,1.23 [1.08-1.40],0.0019221735921043
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT1,Angiopoietin-1,24111,1392,1.06 [1.00-1.12],0.0422707000129365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,24400,1401,1.48 [1.32-1.67],5.885608681517681e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,23875,1378,1.31 [1.11-1.54],0.0012344164968664
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,24271,1407,1.23 [1.10-1.36],0.0001218712424977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,24400,1401,1.24 [1.10-1.40],0.0005390339665319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,23615,1355,1.18 [1.12-1.25],9.179812226822255e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA2,Annexin A2,20274,1176,1.11 [1.03-1.19],0.0047302142831323
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA5,Annexin A5,23545,1353,1.23 [1.05-1.45],0.0101804801588303
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,21007,1211,1.07 [1.01-1.15],0.0348598871565442
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24101,1383,1.11 [1.01-1.23],0.0382638682737543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APCS,Serum amyloid P-component,20972,1213,1.36 [1.17-1.60],0.0001065811593465
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,24200,1394,0.76 [0.69-0.83],3.649175153600969e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOA2,Apolipoprotein A-II,21143,1218,1.12 [1.01-1.25],0.0379089857454554
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APOF,Apolipoprotein F,21143,1218,0.68 [0.55-0.84],0.0002879001699415
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APP,Amyloid-beta precursor protein,24157,1393,1.10 [1.03-1.18],0.0060944049769701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,24101,1383,1.40 [1.28-1.53],1.2831427402161336e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,24143,1396,1.06 [1.02-1.11],0.0090720243604945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSA,Arylsulfatase A,24192,1398,1.11 [1.00-1.23],0.0414032822894378
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARSB,Arylsulfatase B,24101,1383,1.13 [1.03-1.22],0.0060369768552783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ARTN,Artemin,23703,1359,1.12 [1.05-1.21],0.0013714825106706
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASAH1,Acid ceramidase,20916,1205,1.14 [1.01-1.28],0.0331585326677165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,24033,1375,2.19 [1.89-2.55],5.38708291624386e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,21143,1218,1.68 [1.38-2.03],1.504239626220823e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATOX1,Copper transport protein ATOX1,24272,1406,1.10 [1.03-1.18],0.0053938519754676
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATP6AP2,Renin receptor,23618,1368,1.15 [1.04-1.27],0.0070948675852256
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,21010,1209,1.25 [1.05-1.48],0.0119792325764589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AXIN1,Axin-1,24143,1396,1.07 [1.01-1.12],0.0124561154981585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,21172,1227,1.30 [1.10-1.53],0.0022031450711827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20595,1191,1.37 [1.18-1.60],4.999158315068169e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",24314,1410,1.43 [1.21-1.70],2.941755873259045e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",24192,1398,0.81 [0.67-0.98],0.0337773682949254
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BACH1,Transcription regulator protein BACH1,24143,1396,1.12 [1.05-1.20],0.000483244075141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,20528,1188,1.12 [1.00-1.25],0.0435039587393962
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23618,1368,1.26 [1.17-1.35],8.38086036939785e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,24143,1396,1.05 [1.01-1.10],0.0281716508617062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAX,Apoptosis regulator BAX,23578,1353,1.08 [1.02-1.14],0.008219325343774
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,24033,1375,0.59 [0.51-0.68],1.1792853486216962e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21125,1219,1.23 [1.03-1.47],0.0205170339455216
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2,Apoptosis regulator Bcl-2,21010,1209,1.12 [1.01-1.23],0.0253944351883343
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24143,1396,1.23 [1.10-1.37],0.000178068691097
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCR,Breakpoint cluster region protein,24143,1396,1.07 [1.02-1.13],0.006867973677512
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BDNF,Brain-derived neurotrophic factor,21122,1217,1.08 [1.01-1.16],0.0225389395801446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BECN1,Beclin-1,20595,1191,1.13 [1.03-1.23],0.0086326676093279
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BGLAP,Osteocalcin,21122,1217,0.91 [0.86-0.97],0.0024173424987733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,20675,1203,1.93 [1.66-2.25],2.1176183298501186e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20528,1188,1.15 [1.02-1.29],0.0230083928812669
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BOLA1,BolA-like protein 1,20435,1186,1.18 [1.08-1.29],0.000285709285698
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFA2,BPI fold-containing family A member 2,19834,1144,0.90 [0.85-0.95],0.0003281511634342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,24126,1399,1.19 [1.10-1.29],2.1309668080289497e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BRK1,Protein BRICK1,23615,1355,1.13 [1.02-1.26],0.0206394599698533
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,24392,1408,1.85 [1.46-2.33],2.498260206394095e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,24408,1403,1.25 [1.16-1.34],6.5948136343341875e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTLA,B- and T-lymphocyte attenuator,20372,1173,1.07 [1.02-1.13],0.0105430391291211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,24314,1410,1.45 [1.22-1.74],3.336831918148206e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,24143,1396,1.32 [1.17-1.48],2.413786844467597e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,23615,1355,1.08 [1.00-1.16],0.0368419890526615
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QL2,Complement C1q-like protein 2,20528,1188,0.86 [0.75-0.98],0.0275029030726305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20632,1201,0.85 [0.76-0.95],0.0037118322698286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C5,Complement C5,21172,1227,1.59 [1.11-2.27],0.0113345885524022
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,20658,1198,1.21 [1.01-1.44],0.0398503518217138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,24400,1401,0.71 [0.62-0.82],1.1567059722535648e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,24485,1416,1.56 [1.29-1.89],6.330828216021847e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",23739,1376,1.13 [1.07-1.19],3.1600446563310137e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,24117,1394,0.82 [0.77-0.89],4.036438829727982e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCA,Calcitonin,23984,1373,1.17 [1.08-1.26],5.57382538128882e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23618,1368,1.13 [1.01-1.25],0.0306274587288625
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,24137,1388,1.69 [1.34-2.13],8.600285942114629e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,23999,1383,1.16 [1.07-1.26],0.0002190470734144
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPS,Calcyphosin,21076,1210,1.06 [1.00-1.12],0.0465256043663593
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASC3,Protein CASC3,20531,1187,1.19 [1.04-1.35],0.0096170982312218
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP1,Caspase-1,23615,1355,1.09 [1.02-1.16],0.0111594358064585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP10,Caspase-10,23615,1355,1.09 [1.01-1.16],0.018675150142265
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CASP2,Caspase-2,24143,1396,1.08 [1.01-1.16],0.0285297517265153
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,24400,1401,0.62 [0.53-0.72],1.6612718790161566e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBS,Cystathionine beta-synthase,20595,1191,1.21 [1.08-1.35],0.0006980996926219
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24033,1375,1.08 [1.02-1.15],0.0153742512187074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,24200,1394,1.39 [1.21-1.59],2.317726889972037e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,24435,1413,1.24 [1.10-1.41],0.0005363516775015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,24105,1392,1.20 [1.07-1.34],0.0012857924730051
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,24485,1416,1.29 [1.17-1.42],6.61533828338097e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,24485,1416,1.26 [1.15-1.39],1.015217264153002e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,24166,1400,1.18 [1.12-1.24],1.7172462307357308e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,23825,1381,1.07 [1.01-1.14],0.0250419616322689
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,24408,1403,1.04 [1.00-1.07],0.0352494809157837
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,24435,1413,1.16 [1.10-1.21],4.257999470410115e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,24314,1410,1.22 [1.10-1.34],7.046724863284478e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,23981,1394,1.29 [1.18-1.40],7.902110544114269e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,24314,1410,1.29 [1.15-1.44],9.6988442897284e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,24435,1413,1.23 [1.12-1.35],2.2243991029568387e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL26,C-C motif chemokine 26,24143,1396,1.07 [1.02-1.12],0.0076426418153068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,24200,1394,1.19 [1.10-1.29],2.6718871635436487e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,24072,1392,1.19 [1.10-1.28],5.09420956922602e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,24143,1396,1.20 [1.13-1.28],6.232231260876317e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL4,C-C motif chemokine 4,24237,1405,1.10 [1.03-1.17],0.0024613307419086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,24267,1406,1.10 [1.05-1.15],5.0588756713643024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,24143,1396,1.32 [1.24-1.41],5.3862212502760666e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,24056,1380,1.16 [1.09-1.23],1.960581298961151e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN2,CCN family member 2,24194,1402,1.11 [1.02-1.20],0.0129655898202302
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,24451,1416,1.40 [1.22-1.61],1.7917171719000338e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,24400,1401,1.20 [1.08-1.34],0.00106270522093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,21010,1209,1.22 [1.06-1.41],0.0056585707540213
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,23655,1370,1.40 [1.25-1.57],2.892488617281125e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD207,C-type lectin domain family 4 member K,23711,1357,1.26 [1.11-1.42],0.0002759981934381
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD209,CD209 antigen,24252,1407,0.83 [0.74-0.93],0.0015261415033114
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,21122,1217,0.75 [0.66-0.86],3.840474900892241e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,24272,1406,1.35 [1.20-1.51],2.258440289479073e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,24033,1375,1.45 [1.28-1.66],1.6547858944265783e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD276,CD276 antigen,24201,1404,1.21 [1.06-1.38],0.0059815252305862
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD2AP,CD2-associated protein,24200,1394,1.10 [1.03-1.19],0.0072356554810016
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300A,CMRF35-like molecule 8,20675,1203,1.25 [1.03-1.50],0.0215212337546728
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,24408,1403,1.29 [1.13-1.48],0.0001828209556518
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,24314,1395,1.42 [1.27-1.59],1.1466212950202095e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,24400,1401,1.12 [1.04-1.22],0.0054109179718851
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,24101,1383,1.75 [1.51-2.03],1.1113875480192831e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,24323,1401,0.68 [0.56-0.82],8.557166398141473e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,24107,1393,1.55 [1.41-1.71],2.8038914623531614e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,24194,1402,1.15 [1.05-1.26],0.0029832855290321
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD46,Membrane cofactor protein,24018,1387,1.41 [1.22-1.64],3.631260394479967e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD5,T-cell surface glycoprotein CD5,24365,1399,1.54 [1.35-1.75],4.395046285490122e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD55,Complement decay-accelerating factor,23326,1347,1.26 [1.07-1.48],0.0050313497785237
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,23272,1327,1.60 [1.31-1.96],5.974994481312544e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD6,T-cell differentiation antigen CD6,24392,1408,1.14 [1.04-1.24],0.0031345647818149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,24408,1403,1.32 [1.16-1.51],4.162570801046334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,24435,1413,1.12 [1.01-1.25],0.0329580749442708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,21125,1219,1.33 [1.13-1.56],0.0006122942091876
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,24143,1396,1.78 [1.57-2.02],2.974378128716016e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD86,T-lymphocyte activation antigen CD86,21010,1209,0.82 [0.68-0.98],0.0315763678667946
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD93,Complement component C1q receptor,23254,1343,1.19 [1.02-1.38],0.0243607227585306
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,24192,1398,1.59 [1.31-1.92],1.8977666726872267e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDC27,Cell division cycle protein 27 homolog,23618,1368,1.13 [1.04-1.22],0.002105379021058
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,24033,1375,1.66 [1.52-1.81],1.790949267349952e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,23370,1348,1.17 [1.05-1.30],0.0041815381145382
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,24200,1394,1.22 [1.06-1.40],0.004229880069712
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH23,Cadherin-23,21076,1210,0.78 [0.63-0.96],0.0210322622982581
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH5,Cadherin-5,24485,1416,0.79 [0.67-0.93],0.0034839463056342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR1,Cadherin-related family member 1,23615,1355,0.88 [0.78-0.99],0.0361631180671159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,24101,1383,1.13 [1.06-1.20],0.0002497443547997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR5,Cadherin-related family member 5,24200,1394,0.88 [0.78-1.00],0.0436919874220887
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,24101,1383,1.05 [1.01-1.10],0.0202044443558865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21010,1209,0.84 [0.79-0.90],1.1136341898435158e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20717,1204,1.15 [1.04-1.28],0.008780880320135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23317,1345,1.44 [1.36-1.53],1.5722968226456983e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21122,1217,1.99 [1.72-2.29],2.0439461253022565e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,23739,1376,1.20 [1.10-1.31],6.181732008366115e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,24440,1415,0.92 [0.85-1.00],0.0493636854848839
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP43,Centrosomal protein 43,23546,1363,1.10 [1.03-1.18],0.0075257989617747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEP85,Centrosomal protein of 85 kDa,23618,1368,1.09 [1.01-1.18],0.0260022182292073
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,24242,1407,1.11 [1.05-1.18],0.000475026086937
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES2,Cocaine esterase,24101,1383,1.19 [1.10-1.28],2.657122817372548e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CETN2,Centrin-2,23615,1355,1.08 [1.01-1.16],0.0293400467960014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,20768,1201,1.27 [1.07-1.50],0.0067610744250474
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,21172,1227,1.35 [1.01-1.79],0.039526508723849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,19927,1158,1.32 [1.04-1.68],0.023729064927193
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFHR5,Complement factor H-related protein 5,20870,1204,1.17 [1.02-1.34],0.0221573188971544
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,21172,1227,2.01 [1.54-2.64],3.752460654939589e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,24200,1394,1.36 [1.22-1.52],3.024697936790205e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHAD,Chondroadherin,20675,1203,0.83 [0.75-0.91],0.0002167270136944
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21076,1210,1.76 [1.57-1.98],8.331650575803886e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,21007,1211,1.60 [1.37-1.86],2.3620697808949004e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,21122,1217,1.24 [1.18-1.31],5.364141138824703e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,23625,1365,1.40 [1.33-1.48],8.452048857488942e-33
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,24235,1404,0.79 [0.68-0.92],0.0024557629728129
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,24271,1407,1.33 [1.14-1.55],0.0002212184360425
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,21122,1217,1.26 [1.14-1.39],6.65794386993456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,24316,1403,1.94 [1.67-2.26],2.189594641469514e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,21122,1217,1.13 [1.03-1.23],0.0086103586746278
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,24033,1375,1.32 [1.16-1.52],4.3767699982539776e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,24192,1398,1.30 [1.12-1.50],0.0004414509359384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,24408,1403,1.06 [1.01-1.12],0.01330440111267
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,20531,1187,0.89 [0.79-1.00],0.0408986727656601
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,20660,1195,0.52 [0.40-0.68],1.210696376822784e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,24143,1396,0.71 [0.62-0.81],2.728117478812995e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,24143,1396,0.88 [0.79-0.97],0.0139712631711803
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,24143,1396,1.33 [1.24-1.43],5.729328843551927e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,21080,1217,0.82 [0.73-0.91],0.0003937114244056
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,24124,1390,1.59 [1.36-1.86],3.600795943030534e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,23618,1368,1.23 [1.12-1.36],4.081825437304243e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,24435,1413,1.18 [1.08-1.30],0.0003458297651657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,20531,1187,1.22 [1.08-1.37],0.0012358817164106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLIC5,Chloride intracellular channel protein 5,20531,1187,1.20 [1.01-1.42],0.0395566952911365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,24400,1401,1.63 [1.29-2.06],4.752087497553779e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLPS,Colipase,24158,1397,0.93 [0.87-0.99],0.0263773321777914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLUL1,Clusterin-like protein 1,24164,1393,0.79 [0.71-0.87],7.011022770828655e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,24485,1416,0.59 [0.50-0.71],9.0076854349356e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN3,Contactin-3,24192,1398,0.86 [0.75-0.98],0.0283231324573909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN4,Contactin-4,24192,1398,0.70 [0.57-0.85],0.0004112149440569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,24246,1393,0.77 [0.67-0.87],5.178326859638521e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COCH,Cochlin,21125,1219,1.17 [1.05-1.31],0.0051668970818451
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,24286,1408,1.97 [1.61-2.41],5.7427150886385185e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL1A1,Collagen alpha-1(I) chain,24485,1416,0.74 [0.62-0.89],0.0014255403790967
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,20531,1187,0.91 [0.84-0.98],0.0155311287113038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,24485,1416,1.66 [1.46-1.88],1.5776085910213014e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,24143,1396,1.12 [1.02-1.24],0.0191571986017365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,24201,1404,1.79 [1.50-2.14],2.0601603930222072e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMMD1,COMM domain-containing protein 1,20595,1191,1.10 [1.01-1.21],0.0302584906780255
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COMT,Catechol O-methyltransferase,23495,1360,1.07 [1.01-1.13],0.0247893520804808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20595,1191,1.15 [1.02-1.30],0.0207211369412968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CORO1A,Coronin-1A,23680,1375,1.07 [1.01-1.12],0.0120870992312596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,24295,1398,1.42 [1.24-1.63],4.605418733719873e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20528,1188,1.29 [1.08-1.55],0.0053575923149848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,24408,1403,1.08 [1.01-1.16],0.0274327677127502
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM1,Probable carboxypeptidase X1,24272,1406,1.12 [1.05-1.20],0.0006609371809673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,21125,1219,1.25 [1.00-1.56],0.0483759420494063
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CR2,Complement receptor type 2,24267,1406,0.85 [0.77-0.94],0.0018327012644515
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,23871,1390,1.23 [1.09-1.38],0.0008163171737923
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,20675,1203,1.45 [1.25-1.68],6.201044468176746e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,24271,1407,1.15 [1.05-1.26],0.0022067214209413
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRH,Corticoliberin,23579,1367,0.94 [0.89-1.00],0.0452043555774729
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,24201,1404,1.29 [1.09-1.52],0.003256516266761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,24033,1375,1.32 [1.17-1.49],9.235398216843666e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,24400,1401,0.82 [0.76-0.88],4.9401050494317333e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,20948,1201,0.75 [0.61-0.92],0.004668355593637
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,24314,1410,1.53 [1.30-1.80],3.9532093995880666e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24033,1375,1.08 [1.00-1.17],0.0474306000725054
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3,Granulocyte colony-stimulating factor,23703,1359,1.12 [1.01-1.23],0.027191324303426
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,21122,1217,0.76 [0.65-0.89],0.0008648243378789
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,24233,1405,1.85 [1.59-2.15],1.0394909566099118e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST6,Cystatin-M,23551,1344,0.89 [0.80-0.99],0.0291655016989305
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,24237,1405,1.09 [1.04-1.14],0.0002114565663108
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,23836,1382,1.42 [1.27-1.59],3.90413499154342e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTBS,Di-N-acetylchitobiase,20843,1200,1.30 [1.06-1.61],0.0123697806107389
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,21122,1217,1.42 [1.17-1.72],0.0003365293407909
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRC,Chymotrypsin-C,24202,1403,0.87 [0.81-0.94],0.0002622039108661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,21076,1210,0.84 [0.77-0.91],2.7269660237671985e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,24162,1403,1.17 [1.05-1.30],0.004101007565494
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,22576,1303,1.79 [1.64-1.95],1.5445406934010866e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,24272,1406,1.23 [1.09-1.37],0.0004221073751985
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSH,Pro-cathepsin H,23667,1375,1.07 [1.00-1.14],0.0484643078649588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,24200,1394,1.85 [1.55-2.21],2.1309767215688446e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,24435,1413,1.28 [1.11-1.49],0.0009935145025576
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSS,Cathepsin S,18998,1112,1.36 [1.07-1.73],0.0122588056043677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,24179,1400,1.46 [1.26-1.69],3.236203868143597e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,24143,1396,1.28 [1.18-1.38],6.247834919111619e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL13,C-X-C motif chemokine 13,24408,1403,1.10 [1.03-1.18],0.0043145666783513
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,24443,1415,1.91 [1.56-2.33],2.0303111520696806e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,24435,1413,2.78 [2.55-3.03],6.540870306358869e-123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL5,C-X-C motif chemokine 5,24124,1389,1.05 [1.01-1.09],0.0246458346704735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,23995,1387,1.15 [1.08-1.23],1.3680952052875571e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,24314,1410,1.17 [1.10-1.26],2.163947014663175e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,20757,1196,1.12 [1.02-1.23],0.0143944446101209
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CYTL1,Cytokine-like protein 1,21122,1217,1.30 [1.04-1.62],0.0191280664718968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DAPK2,Death-associated protein kinase 2,20528,1188,1.12 [1.02-1.23],0.0198162771584384
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DBI,Acyl-CoA-binding protein,24075,1394,1.08 [1.02-1.15],0.0099700716008479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCC,Netrin receptor DCC,20531,1187,0.70 [0.53-0.92],0.010151356128766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCXR,L-xylulose reductase,24272,1406,1.10 [1.01-1.20],0.0282421100321435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24101,1383,1.31 [1.19-1.45],6.062688820949484e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,24408,1403,1.30 [1.07-1.58],0.008707278593438
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24143,1396,1.05 [1.00-1.11],0.0429040062789259
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,23678,1375,1.10 [1.01-1.19],0.0370118305250604
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,23882,1373,1.08 [1.05-1.12],2.600164141592518e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,24435,1413,1.10 [1.03-1.18],0.0068970066854086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DKKL1,Dickkopf-like protein 1,24101,1383,0.94 [0.89-1.00],0.0435522843024459
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,24272,1406,1.34 [1.15-1.57],0.0002297451833764
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,20595,1191,0.83 [0.76-0.90],1.4635855968678817e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,21010,1209,1.09 [1.00-1.18],0.0452843379899346
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,24160,1401,0.69 [0.57-0.84],0.0001601770314331
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNM3,Dynamin-3,21095,1216,1.11 [1.01-1.22],0.035685177894151
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DNMBP,Dynamin-binding protein,24033,1375,1.12 [1.04-1.20],0.0040836560255598
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DOK2,Docking protein 2,24200,1394,1.04 [1.00-1.09],0.0329764188002642
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPEP1,Dipeptidase 1,23984,1373,0.87 [0.79-0.96],0.00343027500749
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,24143,1396,1.49 [1.33-1.68],1.8299310208447983e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP4,Dipeptidyl peptidase 4,23707,1367,0.81 [0.69-0.95],0.0081533485768341
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,24101,1383,0.58 [0.51-0.67],3.1398629265891025e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,23997,1381,1.19 [1.10-1.29],2.5771744793068468e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,24318,1397,1.18 [1.10-1.27],5.398107714674243e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSC2,Desmocollin-2,23938,1386,1.17 [1.03-1.33],0.0183604027272943
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,21095,1216,0.76 [0.64-0.89],0.0007063272211262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DSG2,Desmoglein-2,24192,1398,0.79 [0.66-0.94],0.0076382297403296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,20971,1211,1.30 [1.15-1.46],2.180566152871358e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24101,1383,1.28 [1.05-1.57],0.0150482668806158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,21007,1211,1.14 [1.00-1.30],0.042717436501925
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECE1,Endothelin-converting enzyme 1,23615,1355,0.85 [0.75-0.98],0.0208536293743516
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21125,1219,1.15 [1.08-1.24],6.13190385680819e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",20595,1191,1.11 [1.05-1.17],0.0004017480978801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,24400,1401,1.51 [1.33-1.71],1.2604106401587856e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,24143,1396,0.94 [0.90-0.99],0.0234880332035726
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,23739,1376,1.44 [1.27-1.64],1.672966167384856e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,20595,1191,1.88 [1.56-2.26],2.5434408395566585e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EEF1D,Elongation factor 1-delta,21125,1219,1.07 [1.01-1.13],0.0213699475282357
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,21010,1209,1.60 [1.34-1.90],1.7446117591772077e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24225,1405,1.24 [1.06-1.44],0.0058598539259423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,24154,1398,1.75 [1.49-2.06],1.3992699180475231e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,23992,1371,1.67 [1.44-1.94],2.3564306150338598e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,23618,1368,1.29 [1.16-1.44],5.547490457154625e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFLAM,Pikachurin,21010,1209,1.35 [1.14-1.59],0.0003522091634969
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,24485,1416,0.44 [0.33-0.58],9.908188246678358e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,24143,1396,1.20 [1.12-1.29],2.2673408729732285e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",20938,1206,1.06 [1.01-1.11],0.0252028151670881
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24200,1394,1.11 [1.03-1.19],0.0040592032911132
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24435,1413,1.06 [1.01-1.11],0.0197752933511977
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,21125,1219,1.56 [1.35-1.81],3.272765352643488e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELOA,Elongin-A,24101,1383,1.11 [1.02-1.20],0.010730620964857
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENAH,Protein enabled homolog,23703,1359,1.11 [1.00-1.23],0.0455927747080777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,19487,1115,0.82 [0.73-0.93],0.0012908542885385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24314,1410,0.84 [0.75-0.93],0.0011465353161316
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23439,1354,1.13 [1.07-1.19],6.937236656660331e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,20595,1191,1.10 [1.00-1.21],0.0485649338496159
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA1,Ephrin type-A receptor 1,24278,1410,1.19 [1.03-1.36],0.014800617744342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,23364,1338,1.49 [1.29-1.72],7.558930531349107e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA4,Ephrin type-A receptor 4,20675,1203,0.77 [0.63-0.93],0.0079967346402192
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,24485,1416,1.48 [1.25-1.76],8.051807809115835e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPO,Erythropoietin,24143,1396,1.11 [1.04-1.17],0.0005980161689735
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPPK1,Epiplakin,20595,1191,1.16 [1.08-1.24],1.5601565880946162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24357,1400,1.35 [1.16-1.58],0.0001365381636015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,24272,1406,1.25 [1.03-1.51],0.0246375350869307
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,24272,1406,0.82 [0.68-0.99],0.0433415288595999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EREG,Proepiregulin,23984,1373,1.10 [1.04-1.16],0.0013476276181366
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERI1,3'-5' exoribonuclease 1,20717,1204,1.26 [1.09-1.45],0.0016878679461498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,24485,1416,1.31 [1.14-1.51],0.0001970629026215
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ESM1,Endothelial cell-specific molecule 1,24201,1404,0.82 [0.71-0.94],0.0034271543249976
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,24408,1403,1.50 [1.24-1.81],2.5789051120134283e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F10,Coagulation factor X,21143,1218,1.37 [1.09-1.73],0.0076898255700072
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F11R,Junctional adhesion molecule A,24192,1398,1.14 [1.05-1.24],0.0015871735180531
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F13B,Coagulation factor XIII B chain,21041,1221,1.31 [1.06-1.63],0.01291676810579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F2R,Proteinase-activated receptor 1,24271,1407,1.09 [1.01-1.19],0.0286084087057155
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F7,Coagulation factor VII,24232,1402,1.24 [1.06-1.45],0.007237376739888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,24226,1403,2.31 [1.78-3.01],3.978119516585627e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",24201,1404,1.21 [1.16-1.27],2.2329383253289533e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",24200,1394,1.13 [1.07-1.19],8.225700357166399e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",21125,1219,1.45 [1.31-1.61],3.923327158117741e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",24485,1416,1.34 [1.22-1.48],4.617665418394763e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,24331,1400,1.12 [1.05-1.20],0.0008915280820322
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,21125,1219,1.94 [1.66-2.27],1.4035388371404312e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,24101,1383,1.36 [1.18-1.56],1.4793648115156094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,24160,1391,1.51 [1.29-1.77],3.0562819479071577e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAP,Prolyl endopeptidase FAP,24485,1416,0.73 [0.61-0.87],0.0004204242104963
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,24408,1411,1.17 [1.01-1.36],0.0412382051060956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,24435,1413,0.80 [0.70-0.90],0.0002755961968883
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",24200,1394,1.10 [1.04-1.18],0.0025762773204801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,24143,1396,1.16 [1.05-1.29],0.0029603479353747
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,21101,1217,1.24 [1.11-1.37],6.750719541573562e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRL1,Fc receptor-like protein 1,24200,1394,0.90 [0.80-1.00],0.0486727234944181
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,23618,1368,1.12 [1.03-1.21],0.0058067940891014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",20461,1174,1.12 [1.04-1.22],0.0048631453187268
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF19,Fibroblast growth factor 19,24314,1410,1.11 [1.04-1.18],0.0010224451248801
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF2,Fibroblast growth factor 2,24143,1396,1.10 [1.03-1.18],0.0068977099768656
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,24361,1398,1.21 [1.16-1.25],6.829848211908798e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,24367,1400,1.28 [1.20-1.36],1.2172505446902631e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,23703,1359,1.19 [1.02-1.39],0.0245664785168037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,24272,1406,0.74 [0.64-0.85],4.8781025952729385e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,24272,1406,1.63 [1.33-2.01],3.955162355514938e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,21143,1218,1.28 [1.18-1.39],8.797740753354672e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,24201,1405,1.08 [1.02-1.15],0.0077130652315356
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24033,1375,1.18 [1.06-1.32],0.0018663704796704
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24033,1375,1.06 [1.01-1.11],0.0291321964589934
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23566,1353,1.12 [1.01-1.23],0.033263935723024
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,23618,1368,0.79 [0.68-0.93],0.0033298183275758
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,24435,1413,1.27 [1.10-1.46],0.0010519021524541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOLR1,Folate receptor alpha,24155,1396,1.26 [1.08-1.48],0.0042368602939571
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXJ3,Forkhead box protein J3,20528,1188,1.13 [1.00-1.27],0.0422669303702091
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO1,Forkhead box protein O1,24143,1396,1.11 [1.05-1.17],0.0002959961811299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FOXO3,Forkhead box protein O3,23618,1368,1.06 [1.01-1.12],0.0233216218959751
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,24271,1407,1.14 [1.05-1.25],0.0033958334829984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,20595,1191,1.97 [1.54-2.51],5.5617088905468224e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,24162,1396,1.92 [1.67-2.20],5.501274084291865e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,21040,1210,1.12 [1.05-1.19],0.0005586983314309
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,20675,1203,1.26 [1.16-1.38],1.5379299513004924e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,24272,1406,1.43 [1.25-1.64],2.6995550634213336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUS,RNA-binding protein FUS,23586,1367,1.14 [1.01-1.28],0.03515130235873
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24408,1403,1.30 [1.18-1.43],2.600878830395031e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FYB1,FYN-binding protein 1,24158,1397,1.07 [1.02-1.13],0.0119159166321652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FZD10,Frizzled-10,20531,1187,1.10 [1.01-1.19],0.0209193851764125
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAGE2A,G antigen 2A,20372,1173,1.10 [1.02-1.19],0.0148773399376468
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,24314,1410,0.82 [0.76-0.89],2.922750429883288e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24101,1383,1.64 [1.41-1.92],5.478552195304797e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24400,1401,0.79 [0.66-0.95],0.0121900431892104
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21125,1219,1.25 [1.03-1.51],0.0259952775167311
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,21076,1210,1.20 [1.16-1.25],3.3428338535406333e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBA,Lysosomal acid glucosylceramidase,20531,1187,1.11 [1.00-1.23],0.0491939845879407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GBP1,Guanylate-binding protein 1,21043,1210,1.14 [1.04-1.24],0.0039389540264852
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCG,Pro-glucagon,23618,1368,1.11 [1.07-1.16],2.206398019497249e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20197,1172,1.49 [1.39-1.60],1.478401235489561e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,24485,1416,2.07 [2.00-2.14],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF2,Growth/differentiation factor 2,24200,1394,0.81 [0.71-0.92],0.0016100835147648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,23618,1368,1.19 [1.11-1.28],2.586487569219962e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,24361,1398,1.77 [1.51-2.09],4.323594379589488e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,20431,1180,0.83 [0.76-0.92],0.0001235505013157
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGH,Gamma-glutamyl hydrolase,23760,1371,1.25 [1.10-1.42],0.0007572102295506
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,24154,1398,1.37 [1.26-1.50],8.652806746426381e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,24033,1375,1.25 [1.01-1.54],0.0398903190869266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH1,Somatotropin,24160,1391,0.96 [0.94-0.99],0.0145420615514154
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GH2,Growth hormone variant,23618,1368,0.97 [0.94-1.00],0.0271045596835196
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GHRL,Appetite-regulating hormone,24200,1394,1.06 [1.00-1.12],0.0460509076690723
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIP,Gastric inhibitory polypeptide,20595,1191,1.22 [1.10-1.35],0.0001408307818387
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,21076,1210,1.45 [1.21-1.73],5.655928379020236e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GKN1,Gastrokine-1,23158,1335,1.28 [1.08-1.52],0.0044061858155594
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,20634,1200,1.57 [1.35-1.81],2.063814340810039e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,24033,1375,1.27 [1.14-1.43],2.615414700634717e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,23739,1376,1.18 [1.09-1.28],3.7036965034736586e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20675,1203,1.07 [1.01-1.14],0.0333694101496683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,20600,1184,1.33 [1.21-1.47],1.7160602079111924e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23618,1368,1.08 [1.00-1.16],0.0479533725177894
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,24408,1403,1.30 [1.07-1.58],0.0092506503583211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23434,1349,0.92 [0.86-0.98],0.0123146415437693
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,21007,1211,1.28 [1.16-1.42],1.376508559836843e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21010,1209,0.91 [0.85-0.98],0.0141708406832033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,23615,1355,1.28 [1.11-1.47],0.0004606836114806
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR15L,Protein GPR15L,21010,1209,1.12 [1.02-1.22],0.0169481536996499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,23739,1376,1.24 [1.15-1.33],5.358389853228213e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,21007,1211,1.26 [1.16-1.37],2.2596915089042244e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,24078,1395,1.30 [1.07-1.58],0.0093694941105239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRP,Gastrin-releasing peptide,20595,1191,1.12 [1.01-1.23],0.03212981157546
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",24101,1383,1.27 [1.18-1.36],1.6294446124336348e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,21074,1209,0.46 [0.37-0.59],1.6972120884162942e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA1,Glutathione S-transferase A1,24166,1390,1.10 [1.04-1.16],0.0018421378504555
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSTA3,Glutathione S-transferase A3,23618,1368,1.08 [1.01-1.14],0.0197251328879504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUCA2A,Guanylin,24076,1393,1.23 [1.07-1.42],0.002858360173965
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,24299,1407,1.19 [1.11-1.28],4.395106819722929e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",23739,1376,1.06 [1.01-1.12],0.0263782390443172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,24400,1401,1.09 [1.05-1.12],2.2672159002194973e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,24365,1399,1.41 [1.32-1.52],1.683013252619715e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,24192,1398,1.68 [1.47-1.92],3.081195960825839e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HBQ1,Hemoglobin subunit theta-1,24400,1401,0.92 [0.85-1.00],0.0426358076921354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,24435,1413,1.10 [1.01-1.20],0.024186819365033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEBP1,Heme-binding protein 1,23739,1376,1.09 [1.01-1.19],0.0336384651424424
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,20675,1203,1.36 [1.12-1.64],0.0015512832822721
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEPH,Hephaestin,21125,1219,1.39 [1.13-1.71],0.0021519602853488
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEXIM1,Protein HEXIM1,24143,1396,1.09 [1.03-1.16],0.0027788792338074
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,24435,1413,1.75 [1.54-1.99],1.1003925851973864e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,21076,1210,1.11 [1.03-1.19],0.0037151444489498
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,21038,1209,1.26 [1.14-1.38],2.575539675467102e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,21095,1216,1.24 [1.09-1.40],0.0006516676898701
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24143,1396,1.38 [1.17-1.62],9.621372917937072e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20595,1191,1.15 [1.04-1.28],0.0083801448787804
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20461,1174,1.14 [1.01-1.29],0.0312922038934046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,23909,1366,1.21 [1.10-1.34],0.0002149555265782
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,23618,1368,0.68 [0.60-0.78],9.970677021457494e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,20835,1207,1.08 [1.02-1.15],0.0078848516158665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS1BP3,HCLS1-binding protein 3,20595,1191,1.08 [1.01-1.15],0.0239604171418319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24101,1383,1.24 [1.10-1.41],0.0006377020555446
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21076,1210,1.13 [1.04-1.24],0.0050115931285211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPB6,Heat shock protein beta-6,24400,1401,1.24 [1.10-1.41],0.0007097021631557
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23981,1386,1.57 [1.32-1.87],3.976584918660482e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",24272,1406,1.09 [1.01-1.17],0.0326322661970507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,24029,1396,1.40 [1.16-1.69],0.0004051764727004
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,24485,1416,1.50 [1.21-1.86],0.0002370771366457
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,24070,1391,1.69 [1.47-1.94],1.1120606410002621e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,24200,1394,1.42 [1.28-1.58],2.599079966541108e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDS,Iduronate 2-sulfatase,24435,1413,0.58 [0.35-0.95],0.032406059474226
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,24400,1401,1.27 [1.14-1.41],7.645916718508862e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20486,1177,1.84 [1.63-2.08],4.250742977656921e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNG,Interferon gamma,23703,1359,1.05 [1.00-1.09],0.0405414189159677
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNL1,Interferon lambda-1,23615,1355,1.12 [1.01-1.24],0.0361647666547945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,24143,1396,1.16 [1.03-1.32],0.0187917267139599
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21122,1217,0.68 [0.56-0.84],0.0002543486620176
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,24192,1398,1.27 [1.03-1.56],0.0244084355582106
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,24441,1415,1.09 [1.01-1.18],0.0225400792609135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,23867,1376,1.89 [1.73-2.06],3.025488742510724e-45
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,24485,1416,1.48 [1.26-1.73],1.2510202693227294e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,24200,1394,1.62 [1.42-1.85],1.4156560929085154e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,21130,1226,1.29 [1.03-1.60],0.0249215055982221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,24101,1383,1.23 [1.07-1.41],0.0033714352904746
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,24200,1394,1.55 [1.33-1.81],2.2841750021826563e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,21125,1219,1.21 [1.13-1.29],6.066339602203266e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IKBKG,NF-kappa-B essential modulator,24143,1396,1.08 [1.02-1.13],0.0056986771530622
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,23703,1359,1.10 [1.02-1.18],0.0156290567351354
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,24314,1410,1.63 [1.39-1.91],2.2788329269311476e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12B,Interleukin-12 subunit beta,24435,1413,0.91 [0.84-0.99],0.0309592033743086
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,23703,1359,1.16 [1.02-1.33],0.0209291171458352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,23890,1381,1.38 [1.10-1.73],0.0047306625395475
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,24143,1396,1.68 [1.47-1.91],7.483715837086533e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL16,Pro-interleukin-16,24435,1413,1.21 [1.08-1.34],0.0005542617061859
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17C,Interleukin-17C,23703,1359,1.10 [1.02-1.18],0.0133351338991718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL17RB,Interleukin-17 receptor B,23832,1368,0.89 [0.82-0.98],0.0133333412658068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,24122,1403,1.25 [1.14-1.38],3.7701870724298167e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,24267,1406,1.48 [1.28-1.72],2.0446980356498376e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,24435,1413,1.29 [1.13-1.48],0.0002317835302819
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,23595,1358,1.16 [1.09-1.25],1.373889503340132e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1B,Interleukin-1 beta,23592,1353,1.15 [1.07-1.25],0.0002226289537935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,24408,1411,1.22 [1.10-1.35],0.0002414081370478
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,23703,1359,0.86 [0.76-0.96],0.0094601758555683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,24159,1403,1.25 [1.16-1.34],3.407390416862991e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL20,Interleukin-20,23703,1359,1.11 [1.01-1.21],0.0224493975624499
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL21R,Interleukin-21 receptor,20528,1188,0.89 [0.80-0.99],0.038945985721727
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,21007,1211,1.19 [1.11-1.28],2.571472962022028e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,24006,1384,1.44 [1.27-1.62],2.4516639889304923e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL3,Interleukin-3,20372,1173,1.10 [1.00-1.22],0.0491978825519355
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL34,Interleukin-34,23578,1353,0.84 [0.74-0.96],0.0087353045936263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,24143,1396,1.44 [1.28-1.63],2.700901637258e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,24143,1396,1.09 [1.00-1.19],0.0467668675168166
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,24101,1383,1.29 [1.23-1.34],8.002509961779283e-29
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,24192,1398,0.80 [0.74-0.87],1.550079620712614e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23579,1351,1.09 [1.00-1.18],0.0448067299124289
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,21007,1211,1.43 [1.31-1.57],3.2773736738026707e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ING1,Inhibitor of growth protein 1,23566,1353,1.14 [1.03-1.25],0.010119916965738
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,20675,1203,1.32 [1.19-1.46],2.678895711180017e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBC,Inhibin beta C chain,24192,1398,1.22 [1.09-1.37],0.0006398750240842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20595,1191,1.22 [1.11-1.34],2.7314433012669835e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24101,1383,1.06 [1.01-1.11],0.0212558877941449
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,21010,1209,1.12 [1.06-1.18],0.0001052142007439
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,23992,1371,1.11 [1.05-1.17],0.0003131198779585
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,24101,1383,1.11 [1.02-1.20],0.0150115255327172
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,23703,1359,1.10 [1.03-1.18],0.0053034193341371
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ISM1,Isthmin-1,24143,1396,1.19 [1.05-1.34],0.0064305915372733
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,24143,1396,0.72 [0.63-0.82],1.7296320306979472e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA2,Integrin alpha-2,20675,1203,0.84 [0.71-0.99],0.041621820000744
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAM,Integrin alpha-M,24192,1398,0.69 [0.59-0.81],4.015196235705333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGAV,Integrin alpha-V,24400,1401,0.44 [0.33-0.58],1.0010478577364755e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB1,Integrin beta-1,24148,1396,0.75 [0.60-0.94],0.0127372807850143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGB2,Integrin beta-2,24022,1391,0.77 [0.64-0.92],0.0032206760413589
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24267,1406,1.24 [1.09-1.42],0.0008895900471766
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20595,1191,1.09 [1.02-1.17],0.0179053585425711
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JAM3,Junctional adhesion molecule C,20675,1203,1.20 [1.08-1.33],0.0005204428475752
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,23703,1359,1.09 [1.01-1.18],0.0270917836011015
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,20680,1187,1.16 [1.03-1.31],0.0159444746677762
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KHK,Ketohexokinase,20595,1191,1.22 [1.12-1.34],6.693150468204153e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23618,1368,1.09 [1.02-1.15],0.0096762855898039
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,23615,1355,0.80 [0.71-0.90],0.0003601508273244
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,24226,1403,0.85 [0.73-0.99],0.0416756830620187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,24200,1394,0.69 [0.61-0.77],3.5532261611377536e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLF4,Krueppel-like factor 4,20435,1186,1.34 [1.18-1.52],3.1661642940919333e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,24192,1404,1.15 [1.03-1.30],0.0174627532634246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,24044,1389,1.19 [1.03-1.39],0.0205591262393786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK13,Kallikrein-13,23688,1351,1.27 [1.14-1.40],9.259885836221456e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK14,Kallikrein-14,24400,1401,1.11 [1.00-1.22],0.0463226172768507
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,24400,1401,1.09 [1.01-1.17],0.0330927880711432
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLRD1,Natural killer cells antigen CD94,24435,1413,1.11 [1.00-1.23],0.0469159215403435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",24101,1383,1.18 [1.12-1.25],3.2453508631869282e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",24108,1395,1.18 [1.10-1.26],1.6013744906493075e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",20435,1186,1.19 [1.11-1.26],1.1093806252066537e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,24435,1413,1.26 [1.14-1.39],5.890419905164308e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24201,1404,1.42 [1.27-1.59],7.205466006039095e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,24314,1410,1.33 [1.16-1.52],4.18262477104659e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,23457,1347,1.34 [1.03-1.74],0.0313575846541844
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,24392,1408,1.77 [1.64-1.90],1.0151844595541322e-52
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAT2,Linker for activation of T-cells family member 2,24101,1383,1.05 [1.01-1.09],0.018346824261849
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,23984,1373,1.47 [1.29-1.69],1.956316127805149e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBP,Lipopolysaccharide-binding protein,24267,1406,1.08 [1.00-1.16],0.044019353869373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,24408,1403,1.13 [1.06-1.20],0.0002207471346542
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,23442,1356,1.27 [1.13-1.42],2.5622362712294976e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LDLR,Low-density lipoprotein receptor,24257,1405,1.12 [1.02-1.23],0.0125396365060262
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,21125,1219,1.17 [1.08-1.27],0.0002522207343587
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,21095,1216,1.23 [1.11-1.36],6.11382824969399e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,24200,1394,1.32 [1.16-1.51],3.1813156249112094e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,24249,1400,1.38 [1.17-1.62],9.504657940136456e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,24201,1404,1.51 [1.39-1.64],1.959523415071858e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS7_LGALS7B,Galectin-7,24113,1384,1.20 [1.06-1.35],0.0027885129565658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS8,Galectin-8,24408,1403,1.10 [1.02-1.19],0.0125812675084662
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,24194,1402,1.60 [1.39-1.84],5.172333250550244e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,24314,1410,1.42 [1.25-1.60],3.0177159887582195e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIF,Leukemia inhibitory factor,23615,1355,1.11 [1.02-1.21],0.018116912416174
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24192,1398,0.87 [0.77-0.99],0.0416979375110779
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24160,1391,1.21 [1.04-1.41],0.0143447449157939
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,23703,1359,1.43 [1.28-1.59],1.2456684173523648e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LIPF,Gastric triacylglycerol lipase,20595,1191,1.19 [1.09-1.31],7.63670207872447e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,21076,1210,1.47 [1.22-1.77],3.676546686644336e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,21095,1216,1.19 [1.04-1.37],0.01379740411059
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",20595,1191,1.08 [1.01-1.15],0.0190478368664013
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,24101,1383,1.16 [1.06-1.26],0.0011588968523579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20461,1174,1.09 [1.01-1.18],0.0335239853682103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,21172,1227,1.69 [1.37-2.07],6.055459557413049e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24326,1396,1.17 [1.02-1.34],0.022911443693907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,24200,1394,1.28 [1.12-1.46],0.0002689509639906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24408,1403,1.11 [1.02-1.19],0.0109675934224057
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,24101,1383,1.30 [1.16-1.46],8.94404339292848e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,23703,1359,0.68 [0.60-0.77],7.925812406016449e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21095,1216,0.73 [0.59-0.90],0.003112120529833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LSP1,Lymphocyte-specific protein 1,24143,1396,1.15 [1.02-1.29],0.0213837792349223
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,24400,1401,1.19 [1.10-1.27],3.019415886034743e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,24485,1416,1.27 [1.09-1.49],0.002385455262776
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,24088,1399,1.59 [1.35-1.86],2.221971864616392e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY6D,Lymphocyte antigen 6D,24078,1397,1.14 [1.00-1.28],0.0427405491802739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,23618,1368,1.11 [1.01-1.23],0.0259799086029123
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,23943,1370,1.22 [1.12-1.32],1.7201908862092887e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,21007,1211,1.24 [1.13-1.36],4.510252788095186e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20595,1191,1.30 [1.05-1.61],0.0174928644645353
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,21125,1219,1.20 [1.09-1.31],0.000113888440033
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MANSC4,MANSC domain-containing protein 4,20461,1174,1.12 [1.03-1.22],0.0090599787315945
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,24143,1396,1.17 [1.05-1.30],0.0055161686050543
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,24243,1405,1.18 [1.01-1.38],0.041059064078913
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN3,Matrilin-3,23992,1371,1.24 [1.07-1.45],0.0043025479734838
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,23618,1368,1.07 [1.02-1.13],0.0104153778995301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCAM,Cell surface glycoprotein MUC18,24267,1406,0.70 [0.62-0.81],3.975049858751081e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,20528,1188,1.08 [1.02-1.15],0.0069231409720239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,24101,1387,1.19 [1.07-1.33],0.0013124699074435
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24033,1375,0.90 [0.84-0.96],0.0024864169690135
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,24205,1401,1.29 [1.19-1.40],1.1710869138932782e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1A,Meprin A subunit alpha,21010,1209,1.25 [1.16-1.35],8.878138832255775e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,24200,1394,0.95 [0.91-0.99],0.0142025110882683
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,24201,1404,0.70 [0.59-0.82],1.4332070460187316e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,24260,1405,0.54 [0.42-0.68],3.100043443298855e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,24192,1398,1.37 [1.23-1.52],5.828065963132224e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24143,1396,1.03 [1.00-1.07],0.0432982027114221
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MLN,Promotilin,24143,1396,1.08 [1.03-1.14],0.0040898467885479
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,24101,1383,1.20 [1.14-1.27],6.531503614532425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP1,Interstitial collagenase,23256,1345,1.12 [1.06-1.18],2.4505731466640743e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,24166,1400,1.09 [1.01-1.18],0.0215435428399101
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,24204,1392,1.79 [1.65-1.93],2.79461125369865e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP3,Stromelysin-1,24192,1398,1.25 [1.14-1.37],2.610795653531685e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,23699,1374,1.37 [1.24-1.52],1.091373928098487e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,24369,1401,1.12 [1.06-1.19],0.0001602760880984
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,24150,1397,1.17 [1.09-1.27],5.567671849561581e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,20675,1203,1.17 [1.08-1.27],0.000116656705138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,23739,1376,1.07 [1.01-1.14],0.0300794936611032
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,24064,1379,1.66 [1.57-1.76],1.1344173749689015e-64
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,24113,1398,1.24 [1.16-1.33],2.0630096169961616e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,24408,1403,1.34 [1.20-1.49],6.522447768140984e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,23739,1376,0.77 [0.71-0.85],5.967997964345205e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTDH,Protein LYRIC,20528,1188,1.07 [1.00-1.13],0.0418295319368297
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTSS2,Protein MTSS 2,21007,1211,1.07 [1.02-1.13],0.0123340558419243
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,20717,1204,1.25 [1.15-1.36],1.2887988742940853e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,23615,1355,1.16 [1.05-1.27],0.0024602750229299
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,23703,1359,1.23 [1.16-1.31],2.6073013922904597e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,20675,1203,0.66 [0.55-0.79],9.900921117041736e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",21125,1219,1.11 [1.02-1.20],0.0120989211583865
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYH4,Myosin-4,20461,1174,1.15 [1.03-1.28],0.011823013742878
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MYL3,Myosin light chain 3,20595,1191,1.10 [1.01-1.19],0.022102258746569
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,24286,1408,1.26 [1.16-1.37],1.1173879217831334e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,21076,1210,0.83 [0.70-0.98],0.0313789053637521
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,24272,1406,1.60 [1.34-1.91],1.4958676979195517e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NBN,Nibrin,23703,1359,1.10 [1.01-1.19],0.0241559294995842
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM1,Neural cell adhesion molecule 1,24267,1406,0.62 [0.52-0.73],2.509005821787473e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAM2,Neural cell adhesion molecule 2,24192,1398,0.74 [0.62-0.89],0.0010740435406443
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,24408,1403,0.66 [0.58-0.74],5.9160297496666976e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21010,1209,1.19 [1.01-1.40],0.0329983811547675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,20461,1174,1.10 [1.01-1.19],0.0259887124800695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,24160,1391,1.72 [1.48-2.00],5.865311162755281e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN4,Nectin-4,24272,1406,1.33 [1.15-1.54],0.0001228619294597
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,23539,1354,1.32 [1.18-1.48],7.252875444745978e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,24272,1406,0.74 [0.66-0.83],1.164436357038691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,24314,1410,0.78 [0.65-0.92],0.0033471204711052
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,24435,1413,1.21 [1.02-1.43],0.0255182371607134
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24143,1396,1.07 [1.02-1.13],0.004242809626783
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",23703,1359,1.13 [1.04-1.22],0.0035141563597145
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,20461,1174,1.10 [1.02-1.19],0.0153957756756829
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,23618,1368,1.18 [1.07-1.30],0.0007321240001401
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,20182,1172,1.64 [1.37-1.97],5.8647005400832283e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID1,Nidogen-1,24182,1397,1.28 [1.15-1.43],1.3366318546536903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NID2,Nidogen-2,24192,1398,1.09 [1.02-1.16],0.0058496593156394
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS1,"Nitric oxide synthase, brain",23615,1355,1.11 [1.01-1.23],0.0282833232103551
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",23615,1355,1.10 [1.01-1.20],0.0349147514087014
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,24485,1416,0.58 [0.43-0.78],0.0003834945847423
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,24485,1416,0.77 [0.68-0.88],0.0001539298863187
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,20767,1196,1.91 [1.73-2.11],1.7945258174129252e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,24200,1394,1.57 [1.37-1.80],1.3832348401372103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPHS2,Podocin,20528,1188,1.06 [1.01-1.11],0.021848120595001
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,21125,1219,1.27 [1.12-1.43],0.0001207579642682
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,23739,1376,1.12 [1.08-1.17],6.551638256492665e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,24192,1398,1.29 [1.15-1.45],1.8099499365407983e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTXR,Neuronal pentraxin receptor,24200,1394,0.83 [0.72-0.95],0.0069719681897626
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPY,Pro-neuropeptide Y,24400,1401,1.15 [1.07-1.23],0.0001999253601138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NRCAM,Neuronal cell adhesion molecule,24200,1394,0.82 [0.69-0.97],0.0220292813093523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,21076,1210,1.58 [1.36-1.84],3.583833027004866e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,24272,1406,1.09 [1.00-1.18],0.0396546073051834
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTF3,Neurotrophin-3,24143,1396,1.14 [1.00-1.30],0.0463053321418239
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,24200,1394,0.70 [0.58-0.84],0.0001325565205416
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,24408,1403,0.48 [0.39-0.59],7.713641722893944e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,24200,1394,1.17 [1.12-1.23],2.7505380238210212e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUCB2,Nucleobindin-2,24362,1398,1.29 [1.14-1.46],5.284394677391669e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20461,1174,1.13 [1.03-1.24],0.0082541177736222
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,24192,1398,1.11 [1.01-1.21],0.0272241441926066
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NUP50,Nuclear pore complex protein Nup50,20461,1174,1.20 [1.03-1.40],0.0183520924240138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NXPH3,Neurexophilin-3,20528,1188,0.76 [0.64-0.91],0.0023032925085979
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,21095,1216,1.83 [1.63-2.04],3.978275197263694e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,23578,1353,0.88 [0.80-0.97],0.0069425949121906
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OGN,Mimecan,24192,1398,1.20 [1.07-1.35],0.0015887457801373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,23972,1383,1.15 [1.07-1.24],0.0001025185891422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,24314,1410,0.69 [0.63-0.76],8.753259625006583e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,24101,1383,0.78 [0.73-0.84],1.0993913137991367e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,21094,1222,2.14 [1.64-2.79],1.8563441646028247e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,24243,1405,1.47 [1.28-1.69],8.137700971388529e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,24032,1391,1.18 [1.11-1.26],4.026714761524426e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,24308,1407,1.49 [1.20-1.85],0.0002482400341062
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20595,1191,1.10 [1.01-1.19],0.0247078039773093
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,24408,1403,1.12 [1.09-1.16],3.3853526418910174e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",P4HB,Protein disulfide-isomerase,24080,1399,1.24 [1.10-1.40],0.0006486295205905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,23739,1376,1.27 [1.17-1.38],3.4842126814750118e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,20595,1191,1.16 [1.05-1.29],0.0044875559924739
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,21076,1210,1.63 [1.44-1.85],2.089163963368321e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,24351,1411,1.25 [1.05-1.47],0.0098982240115373
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,24143,1396,1.16 [1.08-1.24],6.012149443925189e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PAXX,Protein PAXX,20675,1203,1.22 [1.09-1.37],0.0008258440214606
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,23615,1355,1.12 [1.02-1.23],0.0210203904840141
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20636,1203,1.27 [1.14-1.43],2.194050117424436e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH17,Protocadherin-17,24200,1394,0.81 [0.70-0.93],0.0029213793040713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCDH9,Protocadherin-9,21010,1209,0.82 [0.71-0.95],0.0094718693819697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,24485,1416,1.27 [1.13-1.42],8.201669258358604e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDCD5,Programmed cell death protein 5,24408,1403,1.10 [1.01-1.19],0.0257480317787242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,24485,1416,1.10 [1.03-1.17],0.0054046035837525
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,24314,1410,1.08 [1.02-1.14],0.0080599194334901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZD2,PDZ domain-containing protein 2,20461,1174,1.11 [1.01-1.21],0.0242662014922337
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20528,1188,1.28 [1.15-1.44],1.2996337548280846e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PENK,Proenkephalin-A,20675,1203,1.37 [1.15-1.63],0.0003760359259756
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PF4,Platelet factor 4,21016,1220,1.07 [1.01-1.13],0.017642373942854
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,21143,1218,1.23 [1.13-1.34],5.616411627365505e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,24435,1413,1.54 [1.34-1.76],7.391173876311331e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,24364,1410,1.24 [1.12-1.37],4.5041173740697256e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,21010,1209,1.13 [1.02-1.25],0.016466041726037
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24033,1375,1.25 [1.08-1.45],0.0027482560718523
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,23861,1376,1.28 [1.17-1.39],3.100281195415456e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,23886,1382,2.75 [2.47-3.06],5.965083055459413e-77
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24143,1396,1.08 [1.00-1.17],0.0475115736500312
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24192,1398,1.56 [1.32-1.85],2.106480824205713e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,24192,1398,1.40 [1.24-1.57],2.5820786022763334e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,24200,1394,1.22 [1.11-1.33],1.2048384744168566e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PKD2,Polycystin-2,20461,1174,1.11 [1.01-1.21],0.0297194445269888
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,24272,1406,1.68 [1.41-1.99],3.0738526412747807e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G1B,Phospholipase A2,24436,1409,0.79 [0.71-0.89],5.7059030382000976e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",24111,1392,1.13 [1.05-1.21],0.0013439965568968
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,24192,1398,0.85 [0.73-0.98],0.0262582710801718
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,24408,1411,1.31 [1.20-1.44],1.3772722880688742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,24049,1398,3.16 [2.66-3.76],3.5982224719565176e-39
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",21076,1210,0.91 [0.83-1.00],0.0403854261666285
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,21076,1210,1.12 [1.03-1.21],0.0052507501999815
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,20619,1198,1.34 [1.03-1.73],0.0297723930404875
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLIN3,Perilipin-3,24200,1394,1.20 [1.08-1.33],0.0004701051822281
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLTP,Phospholipid transfer protein,24392,1413,0.75 [0.67-0.85],5.518945385089545e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC1,Plexin domain-containing protein 1,23618,1368,0.80 [0.68-0.94],0.0083351859926929
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXDC2,Plexin domain-containing protein 2,21076,1210,0.81 [0.66-1.00],0.0458616440093563
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24077,1383,0.97 [0.94-0.99],0.006038282546917
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,21143,1218,0.89 [0.81-0.97],0.0066328712010772
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,20435,1186,1.19 [1.05-1.34],0.0067578095571005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL,Podocalyxin,24101,1383,0.73 [0.54-0.99],0.0445693305545065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PODXL2,Podocalyxin-like protein 2,24272,1406,0.81 [0.69-0.96],0.017395904442855
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24101,1383,1.38 [1.24-1.54],3.3551199290598507e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POMC,Pro-opiomelanocortin,20595,1191,0.87 [0.80-0.95],0.001685152718588
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,21143,1218,0.66 [0.55-0.79],5.788387035265542e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,23739,1376,1.38 [1.21-1.58],2.747051036772509e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON3,Serum paraoxonase/lactonase 3,24314,1410,0.78 [0.66-0.91],0.0015589436208535
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPBP,Platelet basic protein,21012,1220,1.08 [1.01-1.15],0.019988832173529
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21095,1216,1.28 [1.12-1.45],0.0002001599481246
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPY,Pancreatic prohormone,24180,1396,1.06 [1.01-1.11],0.0170047064603847
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,21122,1217,1.65 [1.45-1.89],1.486832385942688e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,24327,1405,1.23 [1.05-1.44],0.0085090527354665
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRG2,Bone marrow proteoglycan,21122,1217,1.14 [1.02-1.27],0.0181196981090368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,23703,1359,1.15 [1.05-1.25],0.0017032820459541
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20531,1187,0.82 [0.68-0.99],0.0340894961171657
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23618,1368,1.13 [1.05-1.21],0.0010704617275138
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRL,Prolactin,24408,1403,1.08 [1.02-1.14],0.0108687874998458
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,24267,1406,1.21 [1.11-1.31],1.2823102442724451e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS27,Serine protease 27,24124,1390,1.13 [1.01-1.27],0.0353845476172579
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,24117,1402,1.98 [1.79-2.19],5.386195027754739e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRTN3,Myeloblastin,23549,1368,1.12 [1.02-1.23],0.0198584251741958
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRUNE2,Protein prune homolog 2,20717,1204,1.30 [1.10-1.53],0.0017526462515038
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,20922,1209,1.72 [1.51-1.97],2.714344631370929e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,24033,1375,1.05 [1.01-1.10],0.0185595255028005
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,24143,1396,1.12 [1.04-1.20],0.0016434268850349
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSME2,Proteasome activator complex subunit 2,23915,1366,1.17 [1.03-1.32],0.0181496461532308
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,23618,1368,1.08 [1.00-1.17],0.0491508904518139
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,23982,1382,1.33 [1.13-1.56],0.000459147140428
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGES2,Prostaglandin E synthase 2,20355,1181,1.17 [1.06-1.30],0.0019662654268673
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTGR1,Prostaglandin reductase 1,21125,1219,1.08 [1.01-1.16],0.0197151995659814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTN,Pleiotrophin,23739,1376,1.25 [1.14-1.37],1.6228781884301564e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,21125,1219,1.30 [1.09-1.55],0.0034902753471648
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,24485,1416,0.85 [0.72-1.00],0.0495354790023421
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,21010,1209,0.81 [0.72-0.92],0.0007215835436094
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,24106,1395,0.78 [0.64-0.95],0.0119848483500407
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,23947,1373,1.21 [1.04-1.40],0.0118592152233666
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,24485,1416,0.78 [0.65-0.94],0.0107574692768485
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,23512,1343,1.10 [1.01-1.20],0.0274569150863891
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,24143,1396,1.13 [1.03-1.25],0.0128754893800814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,24408,1403,1.33 [1.19-1.49],5.13603796520038e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PYY,Peptide YY,20461,1174,1.21 [1.14-1.27],1.690374338988134e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,24219,1399,1.27 [1.06-1.52],0.0089330497423901
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RAB6A,Ras-related protein Rab-6A,24143,1396,0.88 [0.80-0.97],0.0097963965213547
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,23703,1359,1.10 [1.01-1.19],0.0237376419080454
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,24308,1407,1.49 [1.36-1.62],4.439048031072699e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20372,1173,1.15 [1.02-1.31],0.0247505990965496
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RASSF2,Ras association domain-containing protein 2,23618,1368,1.12 [1.04-1.21],0.0018368751035574
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,21095,1216,1.61 [1.44-1.80],6.24098578970182e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,24101,1383,1.16 [1.10-1.23],2.55713384325301e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,24101,1383,1.29 [1.20-1.40],1.0811355420543435e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,24032,1391,1.29 [1.18-1.42],3.796757750638201e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,24485,1416,1.22 [1.13-1.33],1.0325700571737804e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,24485,1416,1.15 [1.07-1.24],0.0002850080988269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,24243,1405,1.33 [1.21-1.46],1.9990088976803947e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,24192,1398,1.70 [1.44-1.99],1.5416450642084203e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,24200,1394,1.26 [1.18-1.34],6.542906821086104e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RETN,Resistin,24126,1397,1.17 [1.05-1.30],0.0040119323745736
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RFC4,Replication factor C subunit 4,21007,1211,1.36 [1.11-1.67],0.0034063269902869
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,24408,1403,0.72 [0.62-0.84],2.0364473046402875e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20675,1203,1.24 [1.11-1.38],0.0001105844887808
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,21143,1218,1.53 [1.24-1.88],6.607730613334441e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,20595,1191,1.18 [1.05-1.32],0.0038969908389559
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,20450,1176,1.40 [1.16-1.69],0.0004654103646158
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,20988,1209,1.86 [1.61-2.15],2.939897016328918e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,24364,1408,1.51 [1.28-1.78],7.279522602659611e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,20595,1191,1.86 [1.57-2.19],2.4767846952929066e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,23618,1368,1.22 [1.14-1.31],2.98142845520788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,24033,1375,1.37 [1.20-1.56],4.567989817206624e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO3,R-spondin-3,24400,1401,1.44 [1.23-1.70],9.43041578013932e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,24007,1383,1.10 [1.01-1.21],0.0325180109336026
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A12,Protein S100-A12,23883,1377,1.07 [1.00-1.13],0.0394483401860786
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,24143,1396,1.08 [1.01-1.15],0.0183313013992889
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,23585,1349,1.66 [1.44-1.92],9.608883551059692e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF1,Scavenger receptor class F member 1,24485,1416,1.23 [1.10-1.37],0.0002073107639149
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCG2,Secretogranin-2,24288,1393,1.37 [1.19-1.59],1.980941947791886e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,24237,1405,0.64 [0.61-0.68],2.3730449585159266e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,20675,1203,1.27 [1.01-1.58],0.0392632567082383
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,24271,1407,1.20 [1.15-1.25],4.899241599934832e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,24326,1396,1.30 [1.19-1.42],1.8437304746859925e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCN4B,Sodium channel subunit beta-4,20595,1191,1.20 [1.06-1.37],0.0054344970043301
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,20507,1183,1.35 [1.21-1.50],5.7084510150610016e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCT,Secretin,20531,1187,0.87 [0.77-0.99],0.0306462130245827
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEL1L,Protein sel-1 homolog 1,20595,1191,1.32 [1.15-1.52],0.0001192260218319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,24485,1416,1.17 [1.06-1.28],0.0011713002580242
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,21172,1227,0.63 [0.49-0.81],0.0002747449749269
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELL,L-selectin,21172,1227,0.59 [0.47-0.74],5.3963534403073664e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELP,P-selectin,24267,1406,1.14 [1.06-1.24],0.0010454600965595
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,24143,1396,1.38 [1.16-1.64],0.0002966898791573
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEMA3F,Semaphorin-3F,24200,1394,1.27 [1.06-1.53],0.0105737431607314
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,21037,1208,1.45 [1.24-1.69],2.7317899467432617e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,20763,1204,3.19 [1.53-6.63],0.001909206990658
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,21088,1225,1.97 [1.41-2.73],5.843894301162038e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,24435,1413,1.20 [1.12-1.29],3.4608390797411174e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,21123,1225,1.65 [1.35-2.01],1.0061790990291903e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,24485,1416,1.15 [1.07-1.24],0.0001243243287695
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE2,Glia-derived nexin,21125,1219,1.09 [1.01-1.18],0.0248114797235118
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF1,Pigment epithelium-derived factor,20848,1207,1.52 [1.23-1.87],0.0001085377519684
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINF2,Alpha-2-antiplasmin,20769,1207,0.67 [0.45-0.99],0.0425850710591627
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,21123,1225,1.61 [1.20-2.16],0.0013675358166251
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINH1,Serpin H1,20717,1204,1.05 [1.01-1.10],0.01841564283996
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23615,1355,1.09 [1.01-1.17],0.0239571162852319
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEZ6L,Seizure 6-like protein,24272,1406,0.73 [0.61-0.86],0.0002597893412935
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,23955,1371,1.17 [1.05-1.30],0.0059975011646326
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,20675,1203,0.85 [0.74-0.97],0.0154493362161363
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,23618,1368,1.11 [1.03-1.20],0.0052990911523953
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,23618,1368,1.43 [1.34-1.53],1.709370051326919e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,24200,1394,1.18 [1.10-1.26],3.449435073195568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,20758,1193,1.17 [1.06-1.28],0.0010825080650342
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2B3,SH2B adapter protein 3,23618,1368,1.06 [1.01-1.11],0.0269391980934675
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,24143,1396,1.14 [1.06-1.23],0.0005710483689011
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,21122,1217,1.91 [1.61-2.26],1.0050061030624633e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,24232,1402,1.19 [1.08-1.31],0.0005255364487075
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,24314,1410,1.25 [1.12-1.39],6.44693936798996e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24143,1396,1.25 [1.09-1.44],0.0016020418802164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,23615,1355,0.94 [0.88-1.00],0.0428842169094713
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,24200,1394,1.65 [1.41-1.93],7.548613374164057e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20595,1191,1.25 [1.11-1.41],0.000179650839905
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,24365,1399,1.23 [1.04-1.44],0.0133966826439133
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIL1,Nucleotide exchange factor SIL1,20595,1191,1.18 [1.02-1.36],0.0234139302157365
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,24165,1404,1.18 [1.06-1.31],0.0019280030565068
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,23703,1359,1.30 [1.20-1.41],9.897142102752431e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,23984,1373,1.15 [1.08-1.22],1.5032275603993357e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF6,SLAM family member 6,23618,1368,1.20 [1.05-1.36],0.0063185183273143
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,23618,1368,1.16 [1.06-1.28],0.0014858257515861
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,24143,1396,1.10 [1.02-1.19],0.0191969296621885
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC4A1,Band 3 anion transport protein,21122,1217,0.89 [0.79-0.99],0.0356210032975697
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20675,1203,1.08 [1.01-1.15],0.0239591413123486
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,20528,1188,0.63 [0.53-0.75],1.400592853638932e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,24400,1401,0.67 [0.60-0.76],1.635953348239994e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,23739,1376,0.84 [0.73-0.97],0.0180088999337575
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,23618,1368,1.08 [1.02-1.15],0.0070239390566164
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,21007,1211,1.09 [1.01-1.18],0.0289173895885514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,24101,1383,1.39 [1.08-1.78],0.0111831998559105
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,20372,1173,0.88 [0.79-0.98],0.0239022898994956
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,21010,1209,1.10 [1.03-1.19],0.0085538667271833
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,24400,1401,1.37 [1.19-1.58],1.027182111200648e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,24314,1410,1.34 [1.19-1.51],1.6236945593220365e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,24291,1398,1.35 [1.24-1.48],3.5214244462084327e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24278,1410,1.13 [1.05-1.22],0.0009397974620116
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21007,1211,1.10 [1.02-1.18],0.0146125907805504
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,21035,1209,1.06 [1.00-1.12],0.0461384255948999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',21076,1210,1.16 [1.05-1.29],0.0037740101614126
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",24192,1398,1.34 [1.19-1.50],1.1583948728484134e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,23618,1368,1.42 [1.24-1.62],1.7398778022162178e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,24160,1391,1.19 [1.05-1.34],0.0063917002318263
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21095,1216,0.82 [0.67-1.00],0.0462333823173165
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPARC,SPARC,24272,1406,1.13 [1.06-1.21],0.0004093288967482
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPART,Spartin,20675,1203,1.08 [1.00-1.16],0.0377387470406214
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,24192,1398,1.53 [1.40-1.67],1.884321946025669e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,20675,1203,1.19 [1.04-1.37],0.0132030103648036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,24143,1396,1.19 [1.11-1.28],5.048453928356954e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,24400,1401,1.15 [1.06-1.26],0.0016109011567029
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,24123,1395,1.73 [1.47-2.03],2.9526553745646545e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,24314,1410,1.26 [1.12-1.41],5.630298577094493e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPOCK1,Testican-1,24033,1375,0.79 [0.66-0.96],0.0157306417585103
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,24243,1405,1.45 [1.26-1.68],2.65094517931384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,24081,1385,1.48 [1.30-1.69],2.607643627097987e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPRY2,Protein sprouty homolog 2,23703,1359,1.07 [1.01-1.13],0.0127563921686902
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,24101,1383,1.12 [1.04-1.21],0.0033549620167596
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPK2,SRSF protein kinase 2,24143,1396,1.09 [1.03-1.15],0.0035827628658195
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,21125,1219,1.23 [1.04-1.45],0.0156792724557291
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24160,1391,0.92 [0.88-0.96],0.0005505624872907
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24267,1406,1.15 [1.03-1.28],0.0121188880779915
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24485,1416,1.61 [1.37-1.88],2.934048241607988e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,24408,1403,1.21 [1.08-1.35],0.0006708997658368
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX5,Syntaxin-5,20528,1188,0.85 [0.73-0.99],0.0372789058400036
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STX8,Syntaxin-8,24143,1396,1.12 [1.02-1.23],0.0207631135980814
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,24143,1396,1.28 [1.20-1.38],2.1796472453247864e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24408,1403,1.13 [1.03-1.24],0.0096609692991042
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,24192,1398,1.75 [1.57-1.96],7.794361232423927e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,20559,1199,0.80 [0.68-0.95],0.0089719378743296
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,24101,1383,1.24 [1.09-1.41],0.0011114558743742
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,23703,1359,1.10 [1.03-1.17],0.0047276536973505
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,23615,1355,1.07 [1.01-1.14],0.0328340029365046
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAX1BP1,Tax1-binding protein 1,21076,1210,1.10 [1.01-1.20],0.0210849881638028
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,21125,1219,1.39 [1.18-1.63],5.134472353676656e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,21125,1219,1.49 [1.24-1.80],2.7723097021835124e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,24070,1393,1.25 [1.18-1.31],6.067202076235228e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,24271,1407,1.52 [1.42-1.63],6.0488847435728e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,24147,1398,1.31 [1.20-1.42],1.83274936438842e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,24105,1392,1.17 [1.01-1.35],0.0408475072198211
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,24192,1404,1.39 [1.29-1.50],2.4564390060503697e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,24143,1396,1.42 [1.30-1.55],2.1084315260092138e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,24392,1408,1.35 [1.20-1.52],1.1848831142637756e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,24272,1406,1.45 [1.27-1.67],1.244178574047457e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,24192,1398,1.36 [1.21-1.54],7.441384895118267e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,24090,1387,1.24 [1.06-1.45],0.0077139828492169
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THPO,Thrombopoietin,23739,1376,1.17 [1.03-1.31],0.0128792990020419
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,24485,1416,1.13 [1.01-1.26],0.0324370432114352
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23566,1353,1.12 [1.01-1.24],0.0276851594657274
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20717,1204,1.16 [1.01-1.34],0.0411456715654896
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24267,1406,1.14 [1.02-1.26],0.0166474522030444
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,23896,1380,1.72 [1.48-2.01],6.9396997557334266e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,24192,1398,1.24 [1.11-1.39],9.549745423750992e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,24115,1389,0.73 [0.58-0.91],0.0043881379500848
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TJAP1,Tight junction-associated protein 1,24272,1406,1.07 [1.01-1.13],0.0265997701213065
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS15,Enteropeptidase,24101,1383,1.11 [1.06-1.17],5.104687052084289e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,24192,1398,1.12 [1.05-1.19],0.00037665216294
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,23703,1373,1.36 [1.25-1.47],7.125407247293008e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21010,1209,1.18 [1.07-1.30],0.0013662777309987
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24033,1375,1.95 [1.73-2.20],3.914848764192059e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24033,1375,1.83 [1.77-1.88],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24233,1407,1.14 [1.04-1.25],0.0053208674413514
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24435,1413,1.38 [1.23-1.55],4.3325815464936144e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24201,1404,1.37 [1.18-1.59],4.278595550109084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24272,1406,1.81 [1.60-2.05],1.6810380255587182e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24243,1405,1.33 [1.15-1.53],0.0001140412315708
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24243,1405,1.69 [1.46-1.96],3.715444752842153e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24400,1401,1.25 [1.08-1.45],0.0025119912524391
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24192,1398,1.82 [1.57-2.12],2.8888692083031626e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24192,1398,1.58 [1.47-1.68],7.361229438004342e-41
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24392,1408,1.33 [1.18-1.50],2.0762730776083352e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24033,1375,1.47 [1.37-1.58],3.144932205658965e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24033,1375,1.32 [1.17-1.48],3.0316148620671293e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,24143,1396,0.85 [0.79-0.92],4.444457530745255e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,24435,1413,0.82 [0.70-0.96],0.0164621368944995
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,24314,1410,1.62 [1.37-1.92],3.0477948776529386e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24443,1415,1.57 [1.34-1.83],1.0985614285002742e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,24033,1375,1.11 [1.02-1.20],0.0135527283500422
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,24033,1375,0.69 [0.62-0.77],1.001074124187436e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP1,DNA topoisomerase 1,21010,1209,0.94 [0.89-0.99],0.0296846519188986
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TOP2B,DNA topoisomerase 2-beta,20528,1188,1.10 [1.03-1.18],0.005654444527252
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TP53BP1,TP53-binding protein 1,20528,1188,0.91 [0.86-0.98],0.008136213070846
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,21125,1219,1.30 [1.09-1.55],0.003287834388652
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,24045,1394,1.49 [1.38-1.60],7.616813034549256e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPT1,Translationally-controlled tumor protein,23703,1359,0.93 [0.86-1.00],0.042583040085048
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,24201,1404,1.69 [1.55-1.83],1.0204887229723368e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,24400,1401,1.11 [1.03-1.20],0.0044074672866777
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,20671,1201,1.10 [1.01-1.20],0.0225871787252329
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,21010,1209,1.08 [1.02-1.13],0.0076053985871667
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXLNA,Alpha-taxilin,24033,1375,1.09 [1.03-1.15],0.003210820815826
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,24272,1406,1.20 [1.02-1.42],0.0328830794950286
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,24408,1403,1.09 [1.02-1.17],0.01167342214938
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,24036,1383,1.09 [1.01-1.17],0.0204401787250724
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20528,1188,1.10 [1.00-1.20],0.0433939587083089
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21125,1219,1.15 [1.05-1.26],0.0020120536516385
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,24033,1375,1.43 [1.26-1.61],1.090663047957219e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,24411,1409,0.77 [0.71-0.84],8.620626725002611e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UPB1,Beta-ureidopropionase,21125,1219,1.11 [1.05-1.17],0.0004950068321914
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,21007,1211,1.08 [1.00-1.17],0.0423332379848999
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24101,1383,0.67 [0.53-0.86],0.0014556656835241
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,24354,1408,1.24 [1.15-1.33],1.8850490128521564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFC,Vascular endothelial growth factor C,24272,1406,1.09 [1.00-1.19],0.0411702458229994
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,24389,1412,1.17 [1.02-1.35],0.0224933074704469
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VIT,Vitrin,21125,1219,1.22 [1.04-1.42],0.0123088224764064
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,24101,1383,1.11 [1.03-1.19],0.0055355309471266
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,21007,1211,1.47 [1.34-1.60],6.066064291309193e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,24162,1396,1.51 [1.34-1.69],4.827509925622754e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24166,1390,1.10 [1.03-1.18],0.0081424787679661
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,21076,1210,1.21 [1.04-1.40],0.0108472793995659
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20675,1203,1.10 [1.01-1.20],0.0374989910808146
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,24361,1398,1.54 [1.39-1.71],5.901429847828957e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,23943,1369,1.33 [1.18-1.50],4.062139361577216e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",24192,1398,1.20 [1.05-1.36],0.0062173298732287
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,23739,1376,1.06 [1.00-1.11],0.0323039250339761
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,20580,1183,1.16 [1.07-1.26],0.0005565876783997
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,24365,1400,1.15 [1.07-1.24],8.219718047976294e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,22947,1323,2.56 [2.34-2.81],1.8179306868103188e-91
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",23954,1366,0.70 [0.62-0.78],3.7098014371358646e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24243,1405,0.82 [0.72-0.93],0.0030337074617189
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",XCL1,Lymphotactin,24400,1401,1.15 [1.06-1.25],0.0005421288320714
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,21076,1210,1.66 [1.36-2.01],3.542186547614791e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,23739,1376,1.22 [1.11-1.34],5.565503691134362e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZNRD2,Protein ZNRD2,21010,1209,1.08 [1.00-1.17],0.0435351245684936
